Primary amenorrhea
Primary amenorrhea is the absence of menses by 15 years old in the presence of normal growth and secondary sex characteristics. It is usually the result of a genetic or anatomical abnormality; however, all causes of secondary amenorrhea can also present as primary amenorrhea. Evaluation for primary amenorrhea should begin in any patient 13 years of age with no menses and with complete absence of secondary sex characteristics.
Etiology
The most common etiologies of primary amenorrhea are:
- Chromosomal abnormalities causing gonadal dysgenesis (including Turner syndrome)
- Mullerian agenesis, absence of the uterus, cervix and/or vagina
- Physiologic delay of puberty
- Polycystic ovarian syndrome (PCOS)
- Gonadotropin-releasing hormone (GnRH) deficiency
- Transverse vaginal septum
- Weight loss/anorexia nervosa
- Hypopituitarism
Less common etiologies include imperforate hymen, complete androgen insensitivity syndrome, hyperprolactinemia/prolactinoma or other pituitary tumors, congenital adrenal hyperplasia, hypothyroidism, central nervous system defects, craniopharyngioma, and Cushing’s disease.
Physical exam
Physical exam should include:
- Pelvic exam
- Evaluation for intact hymen, clitoral size, and pubic hair development
- Vaginal length, presence of cervix, uterus, and ovaries
- Pelvic ultrasound, as necessary
- Tanner staging for breast development
- Growth assessment (height, weight, arm span, and growth chart, BMI)
- Skin assessment (hirsutism, acne, striae, increased pigmentation and vitiligo)
- Physical features of Turner syndrome: low hairline, webbed neck, shield chest, widely spaced nipples
Diagnosis
Primary amenorrhea is evaluated most efficiently by determining if a uterus is present, as well as focusing on the presence or absence of breast development and initial lab values. Initial laboratory testing should include the following:
- Human chorionic gonadotropin (hCG)
- Follicle-stimulating hormone (FSH) (estradiol [E2] can be helpful if FSH is abnormal)
- Thyroid-stimulating hormone (TSH)
- Prolactin (PRL)
- Free and total testosterone and dehydroepiandrosterone sulfate (DHEAS), if clinical signs of hyperandrogenism are present
Most females with primary amenorrhea have a uterus; of these, most have chromosomal abnormalities causing gonadal dysgenesis. Further evaluation is determined by initial lab results (most importantly FSH), the presence or absence of breast development (as a marker of ovarian function), and the presence or absence of any anatomic abnormalities on physical exam that suggest an outflow tract disorder.
The absence of the uterus during the pelvic exam should be confirmed by pelvic ultrasound. Further evaluation should include karyotype and measurement of serum total testosterone. Distinguishing between abnormal Mullerian development and complete androgen insensitivity syndrome can be aided by history, physical exam, and results of laboratory testing.
Primary Amenorrhea: Interpreting the FSH Level |
Serum FSH level |
Diagnosis/evaluation |
Elevated FSH, with uterus present |
- Primary ovarian insufficiency (POI)
- Gonadal dysgenesis is probable diagnosis (karyotype should be obtained)
- CYP17 deficiency
|
Normal FSH, with blood in uterus/vagina and breast development present |
|
Low/normal FSH, with presence of uterus |
- Central hypothalamic-pituitary disorder
- Congenital GnRH deficiency
- Constitutional delay of puberty
- Outflow tract disorder (anatomic abnormality)
- Systemic illness/endocrine disorder (secondary amenorrhea)
*Note: Evaluation is guided by the degree of pubertal development |
Normal FSH, with absent uterus |
- Mullerian agenesis (testosterone level will be in normal range)
- Androgen insensitivity syndrome (testosterone level will be in male range)
|
Management
Treatment of primary amenorrhea is directed at correcting the underlying pathology (if possible) and prevention of complications of the disease process. Special consideration is directed to the individual patient's treatment goal (i.e., fertility plan, relief of pain, reduction of symptoms, or resumption of menses).